These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 567153)

  • 1. A potency test which simulates natural exposure for measuring post-exposure activity of rabies vaccines. A proposal for preparing a relevant international reference preparation.
    Bijlenga G
    Dev Biol Stand; 1978; 40():203-8. PubMed ID: 567153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Potency testing of inactivated rabies vaccines with the antibody binding test in comparison with the NIH and habel test(author's transl)].
    Oei HL; Krauss H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):1-14. PubMed ID: 1154901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an animal rabies vaccine by use of two types of potency tests.
    Baer GM
    Am J Vet Res; 1997 Aug; 58(8):837-40. PubMed ID: 9256966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Questions concerning the potency of rabies vaccine.
    Crick J; Brown F
    Dev Biol Stand; 1978; 40():179-82. PubMed ID: 355012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-immunization and post-exposure treatment with inactivated rabies vaccine of chick embryo cell culture origin (CEC).
    Kondo A
    Dev Biol Stand; 1978; 40():147-53. PubMed ID: 98373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
    Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
    Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine.
    Fitzgerald EA; Needy CF
    Dev Biol Stand; 1986; 64():73-9. PubMed ID: 3098606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the antibody assay in immunized mice for the determination of rabies vaccine potency.
    Fitzgerald EA; Gallagher M; Hunter WS; Seligmann EB
    Dev Biol Stand; 1978; 40():183-6. PubMed ID: 355013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The phenomenon of "early and stimulated death" in mice infected and then vaccinated against rabies].
    Bijlenga G; Ganeshwaran A; Joubert L; Lery L
    Ann Rech Vet; 1988; 19(2):135-40. PubMed ID: 3415193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of inactivated tissue culture rabies vaccine in dogs.
    Strating A; Bunn TO; Goff MT; Phillips CE
    J Am Vet Med Assoc; 1975 Nov; 167(9):809-12. PubMed ID: 1237485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison studies on potency tests for rabies vaccines.
    Wiktor TJ; Atanasiu P; Bahmanyar M; Boegel K; Cox JH; Diaz AM; Fitzgerald EA; Kuwert E; Netter R; Selimov M; Turner G; van Steenis G
    Dev Biol Stand; 1978; 40():171-8. PubMed ID: 355011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine.
    Sikes RK; Cleary WF; Koprowski H; Wiktor TJ; Kaplan MM
    Bull World Health Organ; 1971; 45(1):1-11. PubMed ID: 5004004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rabies vaccine inactivated with ethylenimine. Duration of the immunity in dogs].
    Larghi OP; Savy VL; Nebel AE; Rodríguez A
    Rev Argent Microbiol; 1979; 11(3):102-7. PubMed ID: 263180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rabies peripheral challenge test: more accurate determination of vaccine potency.
    Wunderli PS; Dreesen DW; Miller TJ; Baer GM
    Vaccine; 2006 Nov; 24(49-50):7115-23. PubMed ID: 16919854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
    Muhamuda K; Madhusudana SN; Ravi V
    Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cytokines concentration and percentage of survival of rabies virus-infected mice submitted to anti-rabies Vero-cell propagated vaccine and P. acnes.
    Megid J; Appolinario CM; Mazzini AM; Almeida MF
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):192-6. PubMed ID: 16930720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines.
    Krämer B; Schildger H; Behrensdorf-Nicol HA; Hanschmann KM; Duchow K
    Biologicals; 2009 Apr; 37(2):119-26. PubMed ID: 19181541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 2 increases protection against experimental rabies.
    Perrin P; Joffret ML; Leclerc C; Oth D; Sureau P; Thibodeau L
    Immunobiology; 1988 May; 177(2):199-209. PubMed ID: 3261273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.